Dr. Nicole Gormley

Nicole Gormley, MD

U.S. Food and Drug Administration

Nicole Gormley, MD, is the Acting Division Director for the Division of Hematologic Malignancies II at the U.S. Food and Drug Administration. Dr. Gormley joined the FDA in 2011 and previously served as a clinical reviewer and the Multiple Myeloma Clinical Team Lead. While in these roles, she has actively engaged with the multiple myeloma community on the development of novel endpoints, including minimal residual disease, and methods to address racial disparities.   Dr. Gormley completed fellowship training in hematology and critical care at the National Institutes of Health and served as the Deputy Clinical Director at the National Heart, Lung and Blood Institute prior to joining the Food and Drug Administration.